
Pediatrix Medical Group, Inc.
MDNYSECIK 893949HealthcareFiscal year ends Dec 31
Reports and events: 259 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-05-1216:43 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-20-140531 |
| 2020-05-0716:26 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001193125-20-136311 |
| 2020-05-0706:52 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-135547 |
| 2020-05-0609:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-134447 |
| 2020-04-2817:16 ET | 10-K/A | Annual report, amendedPeriod 2019-12-31 | 0001193125-20-123354 |
| 2020-04-0716:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-100475 |
| 2020-03-2506:53 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001564590-20-012671 |
| 2020-03-0916:30 ET | 8-K | 8.01 Other events | 0001193125-20-067220 |
| 2020-03-0217:23 ET | SC 13D/A | Ownership report, active investor, amended | 0000921895-20-000633 |
| 2020-02-2006:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-042625 |
| 2020-02-2006:51 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001193125-20-042622 |
| 2020-02-1317:29 ET | SC 13D | Ownership report, active investor | 0000921895-20-000442 |
| 2020-01-1517:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-008166 |
| 2019-12-1106:06 ET | 8-K | 8.01 Other events | 0001193125-19-310607 |
| 2019-11-0106:54 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001193125-19-281135 |
| 2019-11-0106:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-281131 |
| 2019-10-1006:50 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-19-265496 |
| 2019-08-0116:30 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001193125-19-210927 |
| 2019-08-0106:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-209632 |
| 2019-07-0816:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-19-190533 |
| 2019-06-2817:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-19-186223 |
| 2019-05-1717:24 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-19-150702 |
| 2019-05-0216:23 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001193125-19-135054 |
| 2019-05-0206:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-133788 |
| 2019-03-2916:30 ET | DEF 14A | Proxy statementPeriod 2019-05-16 | 0001193125-19-092753 |
| 2019-03-2916:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-19-092716 |
| 2019-03-2806:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-19-089230 |
| 2019-02-2117:00 ET | 8-K | 2.03 New direct financial obligation | 0001193125-19-047118 |
| 2019-02-1416:21 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001193125-19-040891 |
| 2019-02-0706:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-19-030161 |
| 2018-11-2616:50 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-18-333998 |
| 2018-11-1317:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-18-325590 |
| 2018-11-0616:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-18-319651 |
| 2018-11-0116:21 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001193125-18-315785 |
| 2018-11-0106:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-314709 |
| 2018-09-2017:23 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-18-003505 |
| 2018-09-0416:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-18-266272 |
| 2018-08-2817:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-18-260694 |
| 2018-08-0216:30 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001193125-18-236651 |
| 2018-08-0206:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-235580 |
| 2018-05-1717:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-18-166664 |
| 2018-05-0416:28 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001193125-18-152850 |
| 2018-04-3017:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-143735 |
| 2018-03-2316:31 ET | DEF 14A | Proxy statementPeriod 2018-05-16 | 0001193125-18-094194 |
| 2018-03-0816:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-18-075175 |
| 2018-02-1416:54 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001193125-18-045748 |
| 2018-02-0806:51 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-18-035400 |
| 2017-11-1608:30 ET | SC 13D | Ownership report, active investor | 0000902664-17-004368 |
| 2017-11-0116:20 ET | 10-Q | Quarterly reportPeriod 2017-09-30 | 0001193125-17-329442 |
| 2017-11-0106:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-17-328167 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:14 ET. Listed shows no prices and gives no investment advice.